Literature DB >> 28599878

Responsiveness of the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Oxford Knee Score (OKS) in Japanese patients with high tibial osteotomy.

Sabine Goldhahn1, Ryohei Takeuchi2, Norimasa Nakamura3, Ryuichi Nakamura4, Takeshi Sawaguchi5.   

Abstract

BACKGROUND: To assess responsiveness of the Japanese Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Oxford Knee Score (OKS) in patients undergoing open-wedge HTO to treat knee osteoarthritis and/or osteonecrosis.
METHODS: Patients completed a set of questionnaires before HTO surgery (baseline) and 1 year after surgery. The questionnaires comprised the validated Japanese versions of the KOOS, the OKS, and the SF-36v2 and a visual analogue scale (VAS) for local knee pain and general pain. The treating surgeon completed the Japanese Orthopedic Association (JOA) score for osteoarthritic knees. The study included 119 patients aged 64.7 ± 8.3, 116 were followed at 1 year. 90 patients had knee osteoarthritis (OA) solely. 28 patients suffered from both OA and osteonecrosis (ON); one patient had ON only. Responsiveness to change was assessed using the effect size (ES) between the baseline and the 1-year postoperative assessment and standardized response mean. A distribution-based approach was used to determine the minimally detectable change (MDC95) for the KOOS subscales, and the OKS.
RESULTS: All instruments demonstrated statistically significant changes between the preoperative assessments and one year after surgery. All changes showed an improvement in score, but the condition-specific measures revealed higher responsiveness than the generic measures. All KOOS subscales, the OKS, the local pain VAS, and the JOA score showed large ESs (ES > 1.24) and SRMs (SRM>1.04). At a 95% confidence level, the respective MDCs were 15.83, 18.94, 15.22, 18.99 and 17.23 for the KOOS-Pain, KOOS-Symptoms, KOOS-ADL, KOOS-Sport/Rec, and KOOS-QOL subscales, respectively. The MDC95 for the OKS was 8.29.
CONCLUSIONS: Both, the KOOS and OKS are responsive for use in Japanese-speaking patients with knee osteoarthritis and/or osteonecrosis who are undergoing HTO.
Copyright © 2017 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28599878     DOI: 10.1016/j.jos.2017.04.013

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Maturation process of regenerated tissues after single-stage simultaneous autologous particulated cartilage implantation and open wedge high tibial osteotomy for articular cartilage defects with medial osteoarthritis of bilateral knees: a case report.

Authors:  Yasushi Oshima; Norishige Iizawa; Shinro Takai; Tokifumi Majima
Journal:  BMC Musculoskelet Disord       Date:  2021-05-31       Impact factor: 2.362

2.  Additional distal femoral osteotomy for insufficient correction after high tibial osteotomy.

Authors:  Ryuichi Nakamura; Kazunari Kuroda; Masaki Takahashi; Yasuo Katsuki
Journal:  BMJ Case Rep       Date:  2018-08-27

3.  Cross-Cultural Adaptation and Validation of the Hong Kong Version of the Knee Injury and Osteoarthritis Outcome Score (HK-KOOS) for Patients with Knee Osteoarthritis.

Authors:  Andy S K Cheng; Ka-Chun Chan; Sum-Yuet Chan; Miu-Kwan Fan; Man-Kwan Fung; Oi-Yan Lee; Cindy T T Kwok; Jackson K K Wong
Journal:  Occup Ther Int       Date:  2019-08-14       Impact factor: 1.448

4.  Inversed V-shaped High Tibial Osteotomy for Severe Varus Deformity due to Blount Disease: A Case Report.

Authors:  Seiju Hayashi; Kazuhiro Tsukisaka; Tatsunori Aoki; Atsushi Okuhara
Journal:  J Orthop Case Rep       Date:  2021-09

5.  Validation of the Spanish version of the Oxford knee score and assessment of its utility to characterize quality of life of patients suffering from knee osteoarthritis: a multicentric study.

Authors:  Jesús Martín-Fernández; Roberto García-Maroto; Fco Javier Sánchez-Jiménez; Alonso Bau-González; Homero Valencia-García; Blanca Gutiérrez-Teira; Juan Carlos Arenaza; Lidia García-Pérez; Renata Linertová; Amaia Bilbao
Journal:  Health Qual Life Outcomes       Date:  2017-09-29       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.